Medicus Pharma Ltd. (NASDAQ: MDCX) said detailed clinical data from early-stage studies of its long-acting ...

Isomorphic was founded in 2021 as a spin-off from Alphabet's AI research subsidiary, Google ​DeepMind, which is headed by ...

Booster Therapeutics (Germany) focuses on developing small-molecule proteasome activators for neurodegenerative disease using ...

Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...

RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.

West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup financings announced during the annual J.P. Morgan Healthcare Conference this year.

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

Malaria remains a major global public health challenge, with millions of cases reported annually despite sustained control ...

While helping care for cancer patients in Steamboat Springs for 19 years, oncologist and hematologist Dr. Robert Rifkin has ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...